ICD-10-CM Billable Code

G40.C09

Lafora progressive myoclonus epilepsy, not intractable, without status epilepticus

Clinical Classification Guidelines

Inclusion Terms

  • Lafora progressive myoclonus epilepsy NOS

Medical Intelligence & Overview

Lafora progressive myoclonus epilepsy (PME) is a rare, inherited neurological disorder characterized by the development of severe seizures and other neurological symptoms over time. This condition is classified under ICD-10 code G40.C09, indicating a specific form of epilepsy known for its progressive nature. Unlike some epilepsy types that can be controlled easily, Lafora PME tends not to be intractable, meaning it doesn't usually resist treatment, and it does not involve episodes of prolonged seizures called status epilepticus.

Causes & Symptoms

Clinical Causes: Genetic mutations: Lafora disease results from specific gene mutations that lead to abnormal carbohydrate deposits in nerve cells. Inheritance pattern: It is inherited in an autosomal recessive manner, meaning a person must inherit copies of the mutated gene from both parents to develop the disease. Lafora gene mutations: Commonly involves mutations in the EPM2A or NHLRC1 (also known as EPM2B) genes, which play roles in preventing abnormal carbohydrate buildup.

Key Symptoms: Progressive myoclonus: Sudden, involuntary muscle jerks that typically worsen over time. Seizures: Various types, including generalized and partial seizures. Cognitive decline: Deterioration in intellectual abilities, memory issues, and behavioral changes. Visual problems: Including vision disturbances or visual hallucinations in some cases. Neurological decline: Increasing difficulty with coordination, gait, and daily activities. Other signs: Psychiatric symptoms, speech difficulties, and in some cases, decline in overall responsiveness.

Diagnostic & Treatment

Diagnosis Path: Diagnosis involves a combination of clinical assessments, neurological examinations, and specialized tests. These may include:

Treatment Protocols: While there is no cure for Lafora PME, treatment aims to control symptoms and improve quality of life:

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is G40.C09 a billable ICD-10 code?
Yes, G40.C09 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report G40.C09?
Clinical documentation must specify the nature of Lafora progressive myoclonus epilepsy, not intractable, without status epilepticus and any associated comorbidities for accurate reporting.

Cite this Clinical Reference